Researchers inch toward a vaccine for Alzheimer's disease

01/17/2013 | Salon

Researchers at Université Laval and GlaxoSmithKline are reporting success in using monophosphoryl lipid A to stimulate the nervous system's immune response to Alzheimer's disease in mice. Weekly injections of MPL over 12 weeks eliminated up to 80% of brain plaques and improved the mice's cognitive function, researchers say. GSK has used the molecule as a vaccine adjuvant for years.

View Full Article in:

Salon

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC